Singer, E., Hunanyan, L., Melkonyan, M. M., Weber, J. J., Danielyan, L., & Nguyen, H. P. (2021, March). The Novel Alpha-2 Adrenoceptor Inhibitor Beditin Reduces Cytotoxicity and Huntingtin Aggregates in Cell Models of Huntington’s Disease. Pharmaceuticals.
Chicago Style (17th ed.) CitationSinger, Elisabeth, Lilit Hunanyan, Magda M. Melkonyan, Jonasz J. Weber, Lusine Danielyan, and Huu Phuc Nguyen. "The Novel Alpha-2 Adrenoceptor Inhibitor Beditin Reduces Cytotoxicity and Huntingtin Aggregates in Cell Models of Huntington’s Disease." Pharmaceuticals Mar. 2021.
MLA (9th ed.) CitationSinger, Elisabeth, et al. "The Novel Alpha-2 Adrenoceptor Inhibitor Beditin Reduces Cytotoxicity and Huntingtin Aggregates in Cell Models of Huntington’s Disease." Pharmaceuticals, Mar. 2021.
